缝隙连接桥接基础研究与临床眼科
在视网膜神经退行性疾病中,原发靶细胞变性后常引发旁观者效应,使邻近未受累细胞也发生变性。缝隙连接(GJs)被认为介导促死亡信号从受损细胞向邻近细胞扩散,因此GJ阻断被提出作为神经保护策略,但GJs对生理性神经元通讯至关重要,长期抑制可能干扰视觉处理。本文提出替代假说:GJs也可能通过传递保护性「健康信号」促进细胞存活,并探讨其临床效用。
要点
- 视网膜神经退行性疾病中旁观者效应可使继发性细胞死亡超过直接受损细胞数。
- GJs介导促死亡信号扩散,GJ阻断被提议用于糖尿病视网膜病变、缺血和青光眼的神经保护。
- 长期GJ抑制可能破坏视觉处理,限制其在慢性视网膜疾病中的治疗应用。
核心结论
- GJs不仅可能介导神经退行性扩散,还可能通过传递保护性「健康信号」支持细胞存活。
- 将神经保护剂与GJ通透性增强剂联合给药,可能扩大治疗覆盖范围。
研究设计与样本
- 综述文章,汇总GJ介导的细胞间通讯及其在视网膜神经保护中的临床效用。
主要发现
- 旁观者效应中继发性细胞死亡可超过直接受损细胞数量。
- GJs被牵涉于促死亡信号从受损细胞向邻近细胞扩散。
- GJs在生理性神经元通讯中必不可少,长期抑制可能破坏视觉处理。
临床怎么用
- GJ阻断作为神经保护策略需权衡其对生理性视觉处理的潜在干扰。
- 可探索神经保护剂与GJ通透性增强剂联合给药以增强治疗效应。
局限性
- 健康信号假说假设关键内源性分子能通过GJs,但其具体特性和跨连接动态仍知之甚少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In retinal neurodegenerative disorders, the initial degeneration of primary target cells is frequently followed by a phenomenon known as the bystander effect, wherein neighboring, initially unaffected cells also undergo degeneration. This secondary cell death can exceed the number of directly insulted cells (Frantseva et al., 2002a,b; de Rivero Vaccari et al. 2007; Wang et al. 2010; Park et al. 2011; Akopian et al. 2014; O'Brien and Bloomfield, 2018). Although the precise mechanisms underlying the bystander effect remain incompletely understood, gap junctions (GJs) have been implicated in mediating the spread of pro-death signals from injured to adjacent cells. Consequently, GJs have become a focal point in recent research, with GJ blockade proposed as a neuroprotective strategy in progressive retinal diseases, such as diabetic retinopathy, ischemia, and glaucoma. However, GJs are essential in physiological neuronal communication, and their prolonged inhibition may disrupt visual processing (Bloomfield and Völgyi, 2009; Völgyi et al., 2013; O'Brien and Bloomfield, 2018), thereby limiting the therapeutic utility of GJ blockades in the treatment of chronic retinal conditions. Considering this, we propose an alternative hypothesis: rather than solely contributing to neurodegeneration, GJs may also support cell survival by facilitating the intercellular transmission of protective molecules (termed here as 'health-signals') that counteract apoptotic cascades and possibly attenuate the primary insult itself. In this framework, GJs could disseminate "health signals" across the retinal network, suggesting that co-administering neuroprotective agents with GJ permeability enhancers might amplify their therapeutic reach. While this hypothesis assumes that key endogenous molecules can cross GJs, their specific properties and transjunctional dynamics remain poorly understood. This review consolidates current knowledge on GJ-mediated communication and explores its clinical utility in retinal neuroprotection.
引用
- Szarka G, Kovács-Öller T, Hoffmann G, et al. Gap junctions form bridges between bench studies and clinical ophthalmology. Prog Retin Eye Res. 2026. PMID: 42526791. doi:10.1016/j.preteyeres.2026.101505
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。